Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:AMSTSE:ARA.TONASDAQ:BOLTNASDAQ:CME On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSAmerican Shared Hospital Services$2.46+3.8%$2.59$2.32▼$4.60$15.29M0.344,120 shs5,523 shsARA.TOAclara ResourcesC$0.00C$0.00▼C$0.00N/AN/AN/AN/ABOLTBolt Biotherapeutics$5.66+0.4%$6.67$5.20▼$15.60$10.81M0.9110,868 shs14,293 shsCMECME Group$272.10+0.9%$273.65$192.11▼$290.79$97.19B0.452.21 million shs2.53 million shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSAmerican Shared Hospital Services+3.80%+2.07%-1.60%-11.83%-8.21%BOLTBolt Biotherapeutics+0.35%-13.32%-13.64%-35.68%-61.50%CMECME Group+0.89%+0.91%-2.10%+2.09%+38.45%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMSAmerican Shared Hospital Services2.7537 of 5 stars0.05.00.00.02.91.71.9ARA.TOAclara ResourcesN/AN/AN/AN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics3.4658 of 5 stars3.25.00.00.03.11.71.3CMECME Group4.0427 of 5 stars2.13.02.52.92.93.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMSAmerican Shared Hospital Services 0.00N/AN/AN/AARA.TOAclara Resources 0.00N/AN/AN/ABOLTBolt Biotherapeutics 2.33Hold$50.00783.39% UpsideCMECME Group 2.13Hold$258.20-5.11% DownsideCurrent Analyst Ratings BreakdownLatest ARA.TO, AMS, BOLT, and CME Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/4/2025CMECME GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$282.00 ➝ $300.005/24/2025CMECME GroupErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/20/2025BOLTBolt BiotherapeuticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$80.005/13/2025BOLTBolt BiotherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$25.00 ➝ $20.004/25/2025CMECME GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$290.00 ➝ $305.004/24/2025CMECME GroupMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$301.00 ➝ $304.004/24/2025CMECME GroupKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$265.00 ➝ $273.004/24/2025CMECME GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$223.00 ➝ $211.004/23/2025CMECME GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$279.00 ➝ $283.004/11/2025CMECME GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$269.00 ➝ $279.004/8/2025CMECME GroupPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$275.00 ➝ $283.00(Data available from 6/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMSAmerican Shared Hospital Services$28.34M0.56$0.92 per share2.67$4.68 per share0.53ARA.TOAclara ResourcesN/AN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics$7.69M1.41N/AN/A$29.89 per share0.19CMECME Group$6.13B16.00$11.44 per share23.79$73.66 per share3.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMSAmerican Shared Hospital Services$2.19M$0.6011.188.20N/A5.00%-4.20%-2.09%8/12/2025 (Estimated)ARA.TOAclara ResourcesN/AN/A0.00N/AN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics-$63.12M-$33.40N/AN/AN/A-665.56%-94.51%-59.07%8/12/2025 (Estimated)CMECME Group$3.53B$9.9427.3724.763.6657.71%14.03%2.76%7/23/2025 (Estimated)Latest ARA.TO, AMS, BOLT, and CME EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025BOLTBolt Biotherapeutics-$6.80-$5.80+$1.00-$0.29$0.77 million$1.22 million4/23/2025Q1 2025CMECME Group$2.61$2.80+$0.19$2.62$1.56 billion$1.64 billion3/24/2025Q4 2024BOLTBolt Biotherapeutics-$7.60-$7.60N/A-$0.42$0.79 million$0.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMSAmerican Shared Hospital ServicesN/AN/AN/AN/AN/AARA.TOAclara ResourcesN/AN/AN/AN/AN/ABOLTBolt BiotherapeuticsN/AN/AN/AN/AN/ACMECME Group$5.001.84%N/A50.30%N/ALatest ARA.TO, AMS, BOLT, and CME DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CMECME Groupquarterly$1.251.76%6/9/20256/9/20256/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMSAmerican Shared Hospital Services0.581.871.87ARA.TOAclara ResourcesN/AN/AN/ABOLTBolt Biotherapeutics0.483.133.13CMECME Group0.131.021.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMSAmerican Shared Hospital Services23.16%ARA.TOAclara ResourcesN/ABOLTBolt Biotherapeutics86.70%CMECME Group87.75%Insider OwnershipCompanyInsider OwnershipAMSAmerican Shared Hospital Services23.80%ARA.TOAclara ResourcesN/ABOLTBolt Biotherapeutics6.10%CMECME Group0.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMSAmerican Shared Hospital Services106.45 million4.92 millionNot OptionableARA.TOAclara Resources46N/AN/ANot OptionableBOLTBolt Biotherapeutics901.92 million1.80 millionNot OptionableCMECME Group3,760360.36 million359.28 millionOptionableARA.TO, AMS, BOLT, and CME HeadlinesRecent News About These CompaniesState of Alaska Department of Revenue Grows Position in CME Group Inc. (NASDAQ:CME)June 19 at 5:16 AM | marketbeat.comJanney Montgomery Scott LLC Purchases 1,052 Shares of CME Group Inc. (NASDAQ:CME)June 19 at 4:12 AM | marketbeat.comChicago Capital LLC Has $797,000 Stock Position in CME Group Inc. (NASDAQ:CME)June 18 at 4:41 AM | marketbeat.com2,224 Shares in CME Group Inc. (NASDAQ:CME) Bought by Inscription Capital LLCJune 18 at 4:40 AM | marketbeat.com1,206 Shares in CME Group Inc. (NASDAQ:CME) Bought by Brighton Jones LLCJune 18 at 3:58 AM | marketbeat.comCME Group Inc. Announces Second-Quarter 2025 Earnings Release, Conference CallJune 17 at 4:04 PM | prnewswire.com3 Bitcoin-Centric Stocks in Focus Amid Ongoing Geopolitical TensionsJune 17 at 10:21 AM | zacks.comCME Group to Launch Futures on Mexico's IPC IndexJune 17 at 9:00 AM | prnewswire.comDemars Financial Group LLC Has $162.03 Million Stake in CME Group Inc. (NASDAQ:CME)June 17 at 6:46 AM | marketbeat.comQRG Capital Management Inc. Has $9.72 Million Stock Position in CME Group Inc. (NASDAQ:CME)June 17 at 4:44 AM | marketbeat.comExchange Traded Concepts LLC Sells 4,843 Shares of CME Group Inc. (NASDAQ:CME)June 17 at 3:51 AM | marketbeat.comWhat CVOL Convexity Can Tell Us About Market SentimentJune 17 at 1:36 AM | seekingalpha.comFNY Investment Advisers LLC Reduces Stock Holdings in CME Group Inc. (NASDAQ:CME)June 16 at 7:44 AM | marketbeat.comBank Pictet & Cie Europe AG Reduces Stock Position in CME Group Inc. (NASDAQ:CME)June 16 at 5:31 AM | marketbeat.comCME Group Inc. (NASDAQ:CME) Receives $258.20 Consensus Target Price from AnalystsJune 16 at 2:53 AM | americanbankingnews.comTrust Co. of Toledo NA OH Sells 1,109 Shares of CME Group Inc. (NASDAQ:CME)June 15, 2025 | marketbeat.comMn Services Vermogensbeheer B.V. Has $35.46 Million Holdings in CME Group Inc. (NASDAQ:CME)June 15, 2025 | marketbeat.comFairvoy Private Wealth LLC Makes New $847,000 Investment in CME Group Inc. (NASDAQ:CME)June 15, 2025 | marketbeat.comTritonpoint Wealth LLC Sells 1,080 Shares of CME Group Inc. (NASDAQ:CME)June 14, 2025 | marketbeat.com950 Shares in CME Group Inc. (NASDAQ:CME) Purchased by Ipswich Investment Management Co. Inc.June 14, 2025 | marketbeat.comNorthCrest Asset Manangement LLC Purchases 1,570 Shares of CME Group Inc. (NASDAQ:CME)June 14, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueMicrosoft Could Rally as EU Antitrust Case Nears ResolutionBy Chris Markoch | May 21, 2025View Microsoft Could Rally as EU Antitrust Case Nears ResolutionIgnore the Noise—Samsara Stock Is Still a Strong BuyBy Sam Quirke | June 12, 2025View Ignore the Noise—Samsara Stock Is Still a Strong BuyWilliams-Sonoma: A Fundamentally Good Buy On Sale NowBy Thomas Hughes | May 23, 2025View Williams-Sonoma: A Fundamentally Good Buy On Sale NowARA.TO, AMS, BOLT, and CME Company DescriptionsAmerican Shared Hospital Services NYSEAMERICAN:AMS$2.46 +0.09 (+3.80%) Closing price 06/18/2025 04:10 PM EasternExtended Trading$2.43 -0.03 (-1.26%) As of 06/18/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.Aclara Resources TSE:ARA.TOAclara Resources Inc. was incorporated in 2021 and is based in Santiago, Chile.Bolt Biotherapeutics NASDAQ:BOLT$5.66 +0.02 (+0.35%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$5.81 +0.15 (+2.65%) As of 06/18/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.CME Group NASDAQ:CME$272.10 +2.40 (+0.89%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$272.90 +0.80 (+0.29%) As of 06/18/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Chime’s Smart IPO: Half the Valuation, Double the Strength Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow Tesla Bulls and Bears Collide: What Investors Should Know Qualcomm: A Technical Setup Is Emerging, and It's Bullish 330% Returns YTD: Is CoreWeave's Momentum Softening? Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated Microsoft-OpenAI Rift May Cap Stock Upside Potential Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
